In February 2026, The Wall Street Transcript published an exclusive interview with CytoMed Therapeutics Ltd (NASDAQ: GDTC) Chairman Choo Chee Kong. The interview covered the company’s technological approach, clinical trial progress, global strategic expansion — particularly in China and India —…

While the global digital health industry remains focused on specification-driven competition and fragmented use cases, LingSense Bio, a rising Chinese medtech innovator, chose Silicon Valley as the stage to present its answer. At the “BEYOND SLEEP: THE STAREEP PREMIERE” global launch…

Back to top